Vivos Therapeutics raises ~$4.0M via warrant exercise; issues new inducement warrants

Vivos Therapeutics, Inc.

Holder exercises Series B warrant for cash at $4.02/share, yielding ~$4.0M gross proceeds.
Company issues 5-year Series B-1 and 18-month Series B-2 warrants for 735,296 shares each at $5.05.
Inducement transaction expected to close by Feb 20, 2024; proceeds for working capital.
A.G.P./Alliance Global Partners receives 7% cash fee ($280K) plus up to $30K legal expenses.
Company must file resale registration for new warrant shares by Apr 5, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.